These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23332699)

  • 1. Advances in methods to characterize ligand-induced ionic lock and rotamer toggle molecular switch in G protein-coupled receptors.
    Xie XQ; Chowdhury A
    Methods Enzymol; 2013; 520():153-74. PubMed ID: 23332699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.
    Bhattacharya S; Hall SE; Li H; Vaidehi N
    Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of molecular switches in GPCRs--theoretical and experimental studies.
    Trzaskowski B; Latek D; Yuan S; Ghoshdastider U; Debinski A; Filipek S
    Curr Med Chem; 2012; 19(8):1090-109. PubMed ID: 22300046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells.
    Malik RU; Ritt M; DeVree BT; Neubig RR; Sunahara RK; Sivaramakrishnan S
    J Biol Chem; 2013 Jun; 288(24):17167-78. PubMed ID: 23629648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled receptors--recent advances.
    Latek D; Modzelewska A; Trzaskowski B; Palczewski K; Filipek S
    Acta Biochim Pol; 2012; 59(4):515-29. PubMed ID: 23251911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
    Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
    Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the free-energy landscape of GPCR activation.
    Alhadeff R; Vorobyov I; Yoon HW; Warshel A
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10327-10332. PubMed ID: 30257944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
    Tang H; Wang XS; Hsieh JH; Tropsha A
    Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into human GPCR protein OA1: a computational perspective.
    Ghosh A; Sonavane U; Andhirka SK; Aradhyam GK; Joshi R
    J Mol Model; 2012 May; 18(5):2117-33. PubMed ID: 21938455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7TM Domain Structure of Adhesion GPCRs.
    de Graaf C; Nijmeijer S; Wolf S; Ernst OP
    Handb Exp Pharmacol; 2016; 234():43-66. PubMed ID: 27832483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
    Dalton JA; Lans I; Giraldo J
    BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Open Question of How GPCRs Interact with GPCR Kinases (GRKs).
    Cato MC; Yen YC; Francis CJ; Elkins KE; Shareef A; Sterne-Marr R; Tesmer JJG
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capturing Peptide-GPCR Interactions and Their Dynamics.
    Kaiser A; Coin I
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33076289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCR agonist binding revealed by modeling and crystallography.
    Katritch V; Abagyan R
    Trends Pharmacol Sci; 2011 Nov; 32(11):637-43. PubMed ID: 21903279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two arginine-glutamate ionic locks near the extracellular surface of FFAR1 gate receptor activation.
    Sum CS; Tikhonova IG; Costanzi S; Gershengorn MC
    J Biol Chem; 2009 Feb; 284(6):3529-36. PubMed ID: 19068482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.